• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸食含大麻二酚的烟卷后血液和尿液中的大麻素浓度。

Cannabinoid concentrations in blood and urine after smoking cannabidiol joints.

机构信息

Institute of Forensic Medicine of the University of Basel, Health Department Basel-Stadt, Pestalozzistrasse 22, CH-4056 Basel, Switzerland.

Institute of Forensic Medicine of the University of Basel, Health Department Basel-Stadt, Pestalozzistrasse 22, CH-4056 Basel, Switzerland.

出版信息

Forensic Sci Int. 2018 Oct;291:62-67. doi: 10.1016/j.forsciint.2018.08.009. Epub 2018 Aug 11.

DOI:10.1016/j.forsciint.2018.08.009
PMID:30149280
Abstract

In Switzerland, the sale of cannabis with tetrahydrocannabinol (THC) content less than 1% has recently been legalized. As a consequence, cannabis with low THC and high cannabidiol (CBD) values up to approximately 25% is legally available on the market. In this study, we investigated cannabinoid blood and urine concentrations of a naive user and of a modeled chronic user after smoking a single CBD joint. Chronic use was modeled as smoking 2 joints per day for 10 days. Joints contained 200mg of cannabis with THC concentrations of 0.94% and 0.8% and CBD concentrations of 23.5% and 17% in the naive-smoker and chronic-smoker experiment, respectively. After smoking, blood and urine samples were collected for 4 and 20h after smoking start, respectively. THC blood concentrations reached 2.7 and 4.5ng/mL in the naive and chronic user, respectively. In both cases, the blood THC concentration is significantly above the Swiss road traffic threshold of 1.5ng/mL. Consequently, the user was legally unfit to drive directly after smoking. CBD blood concentrations of 45.7 and 82.6ng/mL were reached for the naive and chronic user, respectively. During the 10-day smoking period, blood and urine samples were regularly collected. No accumulation of any cannabinoid was found in the blood during this time. Urinary 11-nor-9-carboxy-THC concentrations seemed to increase during the 10-day period, which is important in abstinence testing.

摘要

在瑞士,最近已将含有低于 1%四氢大麻酚 (THC) 的大麻销售合法化。因此,市场上合法供应 THC 含量低而大麻二酚 (CBD) 含量高(高达约 25%)的大麻。在本研究中,我们研究了一位初次使用者和一位模拟慢性使用者在吸食单一 CBD 烟卷后的血液和尿液中的大麻素浓度。慢性使用通过每天吸食 2 支烟卷且持续 10 天来建模。烟卷中含有 200mg 大麻,其中 THC 浓度分别为 0.94%和 0.8%,CBD 浓度分别为 23.5%和 17%,用于初次使用者和慢性使用者实验。吸烟后,分别在吸烟开始后 4 小时和 20 小时收集血液和尿液样本。初次使用者和慢性使用者的血液 THC 浓度分别达到 2.7 和 4.5ng/mL。在这两种情况下,血液 THC 浓度均明显高于瑞士道路交通的 1.5ng/mL 阈值。因此,使用者在吸烟后直接开车是合法的。初次使用者和慢性使用者的 CBD 血液浓度分别达到 45.7 和 82.6ng/mL。在 10 天的吸烟期间,定期采集血液和尿液样本。在此期间,血液中未发现任何大麻素的积累。尿液中 11-去甲-9-羧基-THC 浓度似乎在 10 天期间增加,这在戒断测试中很重要。

相似文献

1
Cannabinoid concentrations in blood and urine after smoking cannabidiol joints.吸食含大麻二酚的烟卷后血液和尿液中的大麻素浓度。
Forensic Sci Int. 2018 Oct;291:62-67. doi: 10.1016/j.forsciint.2018.08.009. Epub 2018 Aug 11.
2
Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".作为“烟草替代品”吸食富含大麻二酚(CBD)的大麻后,没收的大麻样本以及全血和尿液中的大麻素浓度。
Int J Legal Med. 2019 May;133(3):821-832. doi: 10.1007/s00414-018-01994-y. Epub 2019 Jan 5.
3
Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.经吸食富含大麻二酚的大麻后重复摄入,检测尿液、唾液和毛发样本中的大麻素。
Forensic Sci Int. 2021 Jan;318:110561. doi: 10.1016/j.forsciint.2020.110561. Epub 2020 Nov 1.
4
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.口服液和尿液中“低剂量”大麻使用者大麻素的测定:一项初步研究。
Clin Chem Lab Med. 2018 Dec 19;57(2):238-243. doi: 10.1515/cclm-2018-0566.
5
Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.重组β-葡萄糖醛酸酶水解的优化及通过液相色谱串联质谱法定量测定八种尿中大麻素及其代谢物
Drug Test Anal. 2018 Mar;10(3):518-529. doi: 10.1002/dta.2230. Epub 2017 Aug 16.
6
Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.在吸食植物大麻与合成大麻素药物的个体中观察到的不同生理和行为线索。
Clin Toxicol (Phila). 2016;54(1):14-9. doi: 10.3109/15563650.2015.1101769.
7
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".单次和重复使用“低浓度大麻”后血液、唾液和尿液中的 THC 和 CBD 浓度。
Clin Chem Lab Med. 2020 Apr 28;58(5):682-689. doi: 10.1515/cclm-2019-0119.
8
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.偶吸大麻者吸食大麻卷烟后血浆、唾液和尿液中大麻素浓度的比较。
J Pharm Pharm Sci. 2016 Jul-Sep;19(3):411-422. doi: 10.18433/J3F31D.
9
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?偶尔吸烟者和频繁吸烟者尿液中大麻素的分布:频繁吸烟者尿样中 THC-葡糖苷酸是否是近期使用的标志物?
Clin Chem. 2014 Feb;60(2):361-72. doi: 10.1373/clinchem.2013.214106. Epub 2013 Nov 1.
10
THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects?挪威血液样本中的四氢大麻酚(THC)和大麻二酚(CBD)以及癫痫发作:大麻二酚(CBD)会影响被捕者中四氢大麻酚(THC)引起的损害吗?
Forensic Sci Int. 2017 Jul;276:12-17. doi: 10.1016/j.forsciint.2017.04.006. Epub 2017 Apr 15.

引用本文的文献

1
Quantification of ∆9-tetrahydrocannabinol, 11-OH-THC, THC-COOH, hexahydrocannabinol, and cannabidiol in human plasma and blood by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对人血浆和血液中的∆9 - 四氢大麻酚、11 - 羟基 - 四氢大麻酚、四氢大麻酚酸、六氢大麻酚和大麻二酚进行定量分析。
J Anal Toxicol. 2025 Feb 15;49(2):85-95. doi: 10.1093/jat/bkae094.
2
Enhancement and validation of a quantitative GC-MS method for the detection of ∆9-THC and THC-COOH in postmortem blood and urine samples.用于检测死后血液和尿液样本中 ∆9-四氢大麻酚(∆9-THC)和四氢大麻酚酸(THC-COOH)的定量气相色谱-质谱联用(GC-MS)方法的改进与验证。
MethodsX. 2024 Sep 19;13:102962. doi: 10.1016/j.mex.2024.102962. eCollection 2024 Dec.
3
Determination of Δ-tetrahydrocannabinol, 11-nor-carboxy-Δ-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake.
测定商业大麻二酚油产品摄入后人体血浆和尿液中的Δ-四氢大麻酚、11-羧酸-Δ-四氢大麻酚和大麻二酚。
Forensic Toxicol. 2024 Jul;42(2):191-201. doi: 10.1007/s11419-024-00686-0. Epub 2024 Apr 9.
4
Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device.在口腔液样本中检测大麻素作为即时检测生物传感器诊断设备的首选生物基质。
Biosensors (Basel). 2024 Feb 27;14(3):126. doi: 10.3390/bios14030126.
5
Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial.富含大麻二酚的大麻蒸发对血液中大麻素水平和驾驶能力的影响——一项随机临床试验。
Int J Legal Med. 2023 Nov;137(6):1713-1723. doi: 10.1007/s00414-023-03076-0. Epub 2023 Aug 26.
6
Cannabidiol in urine is not a proof of CBD consumption-lesson learned from urine sample analysis in routine caseworks.尿中的大麻二酚并非 CBD 消费的证据——从常规案例工作中的尿液样本分析中得到的教训。
Forensic Toxicol. 2023 Jul;41(2):213-220. doi: 10.1007/s11419-022-00652-8. Epub 2022 Dec 8.
7
The Determination of Cannabinoids in Urine Samples Using Microextraction by Packed Sorbent and Gas Chromatography-Mass Spectrometry.采用填充吸附剂微萃取与气相色谱-质谱联用技术测定尿样中的大麻素。
Molecules. 2022 Aug 27;27(17):5503. doi: 10.3390/molecules27175503.
8
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis.2003 - 2017年美国大麻、大麻二酚和大麻素在癌症发病率中表现出的地理时空及因果推断性流行病学概述与调查:第1部分 - 连续双变量分析
Arch Public Health. 2022 Mar 30;80(1):99. doi: 10.1186/s13690-022-00811-8.
9
Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction.应用自动化在线固相萃取的气相色谱串联质谱法定量测定血液和尿液中的五种大麻素。
Drug Test Anal. 2022 Jul;14(7):1223-1233. doi: 10.1002/dta.3241. Epub 2022 Feb 28.
10
Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services.低 δ-9-四氢大麻酚产品与合成大麻素掺假:药物检测服务的结果。
Drug Test Anal. 2022 Jun;14(6):1026-1039. doi: 10.1002/dta.3220. Epub 2022 Feb 2.